Apexigen, Inc. Additional Paid in Capital
Apexigen, Inc. had Additional Paid in Capital of $186.57 million as of 2023-06-30, per its 10-Q filed 2023-08-10.
Discontinued › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:AdditionalPaidInCapital · last filed 2023-08-10
- 2023-06-30: Additional Paid in Capital $186.57M.
- 2023-03-31: Additional Paid in Capital $185.96M.
- 2022-12-31: Additional Paid in Capital $183.17M.
- 2022-09-30: Additional Paid in Capital $180.78M.
| Period end | Additional Paid in Capital | Additional Paid in Capital as first filed |
|---|---|---|
| 2023-06-30 | $186.57M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | $185.96M 10-Q · filed 2023-05-15 | |
| 2022-12-31 | $183.17M 10-Q · filed 2023-08-10 | |
| 2022-09-30 | $180.78M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $0.00 10-Q · filed 2022-08-18 | |
| 2022-03-31 | $490.52K 10-Q · filed 2022-05-23 | |
| 2021-12-31 | $166.73M 10-K · filed 2023-02-22 | $490.52K 10-K · filed 2022-04-07 |
| 2021-09-30 | $489.41K 10-Q · filed 2021-12-09 | |
| 2021-06-30 | $5.45M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $5.17M 10-Q · filed 2021-06-07 | |
| 2020-12-31 | $25.83K 10-K · filed 2022-04-07 |